220 related articles for article (PubMed ID: 28249542)
1. Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Li WS; van der Velden JM; Ganesh V; Vuong S; Raman S; Popovic M; Lam H; Wong KH; Ngan RK; Burbach JPM; DeAngelis C; Xxxx RM; Chow E
Ann Palliat Med; 2017 Apr; 6(2):104-117. PubMed ID: 28249542
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
Salvo N; Doble B; Khan L; Amirthevasar G; Dennis K; Pasetka M; Deangelis C; Tsao M; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):408-17. PubMed ID: 21075553
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
[TBL] [Abstract][Full Text] [Related]
4. 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
Ruhlmann CH; Jahn F; Jordan K; Dennis K; Maranzano E; Molassiotis A; Roila F; Feyer P
Support Care Cancer; 2017 Jan; 25(1):309-316. PubMed ID: 27624464
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).
Ades S; Halyard M; Wilson K; Ashikaga T; Heimann R; Kumar S; Blackstock W
Support Care Cancer; 2017 May; 25(5):1503-1510. PubMed ID: 28032216
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.
Dennis K; Jamani R; McGrath C; Makhani L; Lam H; Bauer P; De Angelis C; Coburn N; Wong CS; Chow E
Support Care Cancer; 2017 Jun; 25(6):2019-2033. PubMed ID: 28364173
[TBL] [Abstract][Full Text] [Related]
7. Management of radiation-induced nausea and vomiting.
Abdelsayed GG
Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
[TBL] [Abstract][Full Text] [Related]
9. Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
Jahn F; Riesner A; Jahn P; Sieker F; Vordermark D; Jordan K
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1101-1107. PubMed ID: 26059352
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.
Feyer PCh; Maranzano E; Molassiotis A; Clark-Snow RA; Roila F; Warr D; Olver I
Support Care Cancer; 2005 Feb; 13(2):122-8. PubMed ID: 15592688
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antiemetic studies for radiation-induced nausea and vomiting within an outpatient palliative radiotherapy clinic.
McKenzie E; Chan D; Parsafar S; Razvi Y; McFarlane T; Rico V; Pasetka M; DeAngelis C; Chow E
Support Care Cancer; 2019 Sep; 27(9):3245-3252. PubMed ID: 31119459
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting.
Ahmed H; Hammad AM; Abushouk AI; Zidan M; Salem M; Negida A; Abdel-Daim MM
Curr Probl Cancer; 2018; 42(2):241-255. PubMed ID: 29310827
[TBL] [Abstract][Full Text] [Related]
14. Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
Feyer P; Seegenschmiedt MH; Steingraeber M
Support Care Cancer; 2005 Sep; 13(9):671-8. PubMed ID: 16044252
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.
dos Santos LV; Souza FH; Brunetto AT; Sasse AD; da Silveira Nogueira Lima JP
J Natl Cancer Inst; 2012 Sep; 104(17):1280-92. PubMed ID: 22911671
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
Tramèr MR; Reynolds DJ; Stoner NS; Moore RA; McQuay HJ
Eur J Cancer; 1998 Nov; 34(12):1836-44. PubMed ID: 10023303
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis.
Tricco AC; Blondal E; Veroniki AA; Soobiah C; Vafaei A; Ivory J; Strifler L; Cardoso R; Reynen E; Nincic V; Ashoor H; Ho J; Ng C; Johnson C; Lillie E; Antony J; Roberts DJ; Hemmelgarn BR; Straus SE
BMC Med; 2016 Dec; 14(1):216. PubMed ID: 28007031
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
Benze G; Geyer A; Alt-Epping B; Nauck F
Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
[TBL] [Abstract][Full Text] [Related]
19. Possible role of aprepitant for intractable nausea and vomiting following whole brain radiotherapy-a case report.
Ahuja D; Bharati SJ; Gupta N; Kumar R; Bhatnagar S
Ann Palliat Med; 2016 Oct; 5(4):315-318. PubMed ID: 27701875
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
Horiot JC
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1018-25. PubMed ID: 15519770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
